Virios Therapeutics Stock Forum

$Virios Therapeutics(VIRI.US)$ Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID
Benzinga· 1 min ago

$Virios Therapeutics(VIRI.US)$ Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent.

$Virios Therapeutics(VIRI.US)$ Virios Therapeutics: Discussions Ongoing With Potential Partners to Fund Advancement of IMC-1 Into Phase 3 Development for FM >VIRI
Dow Jones· just

$Virios Therapeutics(VIRI.US)$Moomoo 24/7· 1 min ago
Virios Therapeutics To Advance Development Of IMC-2 As Treatment For Symptoms Associated With Long-COVID

$Virios Therapeutics(VIRI.US)$
we are bubbling here…

$Virios Therapeutics(VIRI.US)$ no no no...

$Virios Therapeutics(VIRI.US)$ looking amazing! something might be brewing

$Virios Therapeutics(VIRI.US)$ Virios Therapeutics Reaches Crucial Agreement with FDA on Long-COVID Treatment Development.

$Virios Therapeutics(VIRI.US)$
November 2, 2023
Dear Virios (VIRI) Shareholders,
We wanted to provide you with a succinct corporate progress report as we exit the third quarter of 2023, which can be summarized as follows:
●
Having secured FDA guidance on our plan to progress IMC-1 to Phase 3 development to treat fibromyalgia, we can convey that several life science companies are engaged and reviewing our Phase 2 data and proposed Phase 3 program as the basis for a potential forward development p...